DNA-PK-IN-1
DNA-PK-IN-1 is a potent inhibitor of DNA-PK. DNA-dependent protein kinase (DNA-PK) is a DNA-PK enzyme complex composed of Ku70/Ku80 heterodimer and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) . DNA-PK-IN-1 has the potential for the research of cancer diseases (extracted from patent WO2021136463A1, compound 1) [1].
Product Specifications
CAS Number
2663850-40-4
UNSPSC
12352005
Target
DNA-PK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dna-pk-in-1.html
Solubility
10 mM in DMSO
Smiles
O=C1N(C)C2=CN=C(NC3=CN4C(C=C3C)=NC=N4)N=C2N1C5(CC6C7)CC7(O)CC(C6)C5
Molecular Formula
C23H26N8O2
Molecular Weight
446.50
References & Citations
[1]Yonggang Wei, et al. Purine derivatives and their use in medicine. Patent WO2021136463A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MAGEA4 (Melanoma-associated Antigen 4, MAGE-4 Antigen, MAGE-X2 Antigen, MAGE-41 Antigen, Cancer/Testis Antigen 1.4, CT1.4, MAGE4, MGC21336) (AP) discontinued
Mouse Monoclonal Aggrecan Antibody (BC-3)
CCNH (Cyclin H, Cyclin-H, MO15-associated Protein, p34, p37) (MaxLight 650)
CCNH (Cyclin H, Cyclin-H, MO15-associated Protein, p34, p37) (MaxLight 650)